Literature DB >> 27743500

Pregnancy outcome in joint hypermobility syndrome and Ehlers-Danlos syndrome.

Heléne E K Sundelin1, Olof Stephansson2,3, Kari Johansson2, Jonas F Ludvigsson4,5,6.   

Abstract

INTRODUCTION: An increased risk of preterm birth in women with joint hypermobility syndrome or Ehlers-Danlos syndrome is suspected.
MATERIAL AND METHODS: In this nationwide cohort study from 1997 through 2011, women with either joint hypermobility syndrome or Ehlers-Danlos syndrome or both disorders were identified through the Swedish Patient Register, and linked to the Medical Birth Register. Thereby, 314 singleton births to women with joint hypermobility syndrome/Ehlers-Danlos syndrome before delivery were identified. These births were compared with 1 247 864 singleton births to women without a diagnosis of joint hypermobility syndrome/Ehlers-Danlos syndrome. We used logistic regression, adjusted for maternal age, smoking, parity, and year of birth, to calculate adjusted odds ratios for adverse pregnancy outcomes.
RESULTS: Maternal joint hypermobility syndrome/Ehlers-Danlos syndrome was not associated with any of our outcomes: preterm birth (adjusted odds ratio = 0.6, 95% confidence interval 0.3-1.2), preterm premature rupture of membranes (adjusted odds ratio = 0.8; 95% confidence interval 0.3-2.2), cesarean section (adjusted odds ratio = 0.9, 95% confidence interval 0.7-1.2), stillbirth (adjusted odds ratio = 1.1, 95% confidence interval 0.2-7.9), low Apgar score (adjusted odds ratio = 1.6, 95% confidence interval 0.7-3.6), small for gestational age (adjusted odds ratio = 0.9, 95% confidence interval 0.4-1.8) or large for gestational age (adjusted odds ratio = 1.2, 95% confidence interval 0.6-2.1). Examining only women with Ehlers-Danlos syndrome (n = 62), we found a higher risk of induction of labor (adjusted odds ratio = 2.6; 95% confidence interval 1.4-4.6) and amniotomy (adjusted odds ratio = 3.8; 95% confidence interval 2.0-7.1). No excess risks for adverse pregnancy outcome were seen in joint hypermobility syndrome.
CONCLUSION: Women with joint hypermobility syndrome/Ehlers-Danlos syndrome do not seem to be at increased risk of adverse pregnancy outcome.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Ehlers-Danlos syndrome; Joint hypermobility syndrome; child; obstetric - cohort study; pregnancy

Mesh:

Year:  2016        PMID: 27743500     DOI: 10.1111/aogs.13043

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

Review 1.  Hypermobile Ehlers-Danlos syndrome and pregnancy.

Authors:  Akilandeswari Karthikeyan; Narayanaswamy Venkat-Raman
Journal:  Obstet Med       Date:  2018-03-20

2.  Ehlers-Danlos syndrome and other heritable connective tissue disorders that impact pregnancies can be detected using next-generation DNA sequencing.

Authors:  Krystal VanderJagt; Merlin G Butler
Journal:  Arch Gynecol Obstet       Date:  2019-06-27       Impact factor: 2.344

3.  Ehlers-Danlos syndromes: state of the art on clinical practice guidelines.

Authors:  Alberto Sulli; Rosaria Talarico; Carlo Alberto Scirè; Tadej Avcin; Marco Castori; Alessandro Ferraris; Charissa Frank; Jürgen Grunert; Sabrina Paolino; Stefano Bombardieri; Matthias Schneider; Vanessa Smith; Maurizio Cutolo; Marta Mosca; Fransiska Malfait
Journal:  RMD Open       Date:  2018-10-18

Review 4.  Considerations for lactation with Ehlers-Danlos syndrome: a narrative review.

Authors:  Jimi Francis; Darby D Dickton
Journal:  Int Breastfeed J       Date:  2022-01-04       Impact factor: 3.461

Review 5.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

6.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.